A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes

Clinical trial NCT01455870 · COMPLETED

Trial details

NCT number: NCT01455870
Sponsor: Intarcia Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2013-05-01
Primary completion: 2015-07-01
Enrollment: 535

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.